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3. Terms and abbreviations 
Terms:  
Alpha rhythm The dominant posterior EEG-rhythm with frequency 8–13 Hz that 
is blocked or attenuated by eye opening 
Background activity Any EEG activity representing the setting in which a given 
normal or abnormal pattern appears and from which such a 
pattern is distinguished 
Database A filing system organised to provide fast access to desired pieces 
of data 
Epilepsy A disorder characterized by spontaneous recurrent episodes of 
paroxysmal brain dysfunction due to a sudden, disorderly, and 
excessive neuronal discharge 
Focal epileptiform 
activity 
Epileptiform activity that is not generalised 
General background 
activity 
The background activity apart from the alpha rhythm 
Generalised 
epileptiform activity 
Epileptiform activity appearing in three or more out of five brain 
regions at both sides at the same time and with not more than 
moderate asymmetry  
Hyperventilation 
provocation 
A procedure implying intentional overbreathing for 3 minutes 
Hyperventilation 
sensitivity 
Epileptiform activity being more than doubled during 
hyperventilation provocation 
Photic stimulation A procedure implying intermittent light flashes in a predefined 
sequence of different frequencies 
Photoparoxysmal 
response 
Generalised epileptiform activity being more than doubled during 
photic stimulation 
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Abbreviations: 
aEEG amplitude-integrated EEG 
AM annotation module 
API application programming interface  
AR alpha rhythm 
ASTM American Society for Testing and Materials 
BA background activity 
BOLD blood-oxygen-level-dependent  
CBRDEE current brain-related disease except epilepsy 
COM component object model  
DM database module 
EAS EEG annotation system 
EEG electroencephalography 
EEGer electroencephalographer 
FEA focal epileptiform activity 
Fig Figure 
fMRI functional magnetic resonance imaging 
GBA general background activity 
GEA generalised epileptiform activity 
HVS hyperventilation sensitivity 
Hz Hertz 
ICD-9 International Classification of Diseases, Ninth Revision 
ICD-10 International Classification of Diseases, Tenth Revision 
IGE idiopathic generalised epilepsy 
JME Juvenile myoclonic epilepsy  
LTM Long term monitoring 
MEG Magnet encephalography 
MFPM multivariate fractional polynomial model 
MPM multivariate polynomial model 
MRI magnetic resonance imaging 
MS Microsoft 
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ODBC open database connectivity  
OR odds ratio 
p probability 
PET positron emission tomography 
PPR photoparoxysmal response 
PSPs postsynaptic potentials 
RBS regular bilateral synchronous 
RGM report generator module 
sec second 
SPECT single photon emission tomography  
SQL structured query language 
TMS transcranial magnetic stimulation 
μV micro-volt 
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4. Introduction 
4.1 EEG 
EEG represents the measurement of fluctuating electrical activity generated from the brain. 
This activity is usually obtained by recording from electrodes placed on the scalp, but can 
also be obtained from electrodes placed directly on the brain cortex or inside the brain 
cortex. The scalp EEG provides an inexpensive, non-invasive measurement of brain state 
fluctuations with high temporal resolution in the range of milliseconds, but, compared to 
modern imaging techniques, with rather low spatial resolution in the range of centimetres 
(Ritter and Villringer, 2006; Tao et al., 2007). 
4.1.1 EEG history 
Already in the late 19th century electrical currents from the surface of exposed brains of 
monkeys and rabbits were reported (Caton R, 1875). Hans Berger published in 1929 the first 
scalp EEG recording from humans (Berger, 1929). The first epileptiform spikes were 
published in 1935 (Kornmuller, 1935). In the 1980s and 1990s the digital computer 
technique was introduced for EEG recordings. This enabled user-selected montages, vertical 
and horizontal scaling, filter adjustments, a far better storage, and faster retrieval of EEGs 
(Burgess, 1993; Nuwer, 1997; Swartz, 1998; Quinonez, 1998; Blum, 1998; Epstein, 2006). 
Such technology also makes it possible to record multi-channel EEG and polygraphic data 
for ambulant patients. Digital video can be simultaneously recorded with EEG, known as 
video EEG telemetry. 
4.1.2 Physiological basis of EEG 
Convoluted dipole layers of pyramidal neurons in the cortical gray matter are the principal 
EEG generators of scalp EEG recordings (Schaul, 1998b). The recorded oscillations 
originate from postsynaptic potentials (PSPs) rather than action potentials. Although action 
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potentials are higher in amplitude, PSPs are longer in duration and involve a larger 
membrane surface allowing both temporal and spatial summation of excitatory and 
inhibitory PSPs. Using simultaneous scalp and intracranial recordings a recent study has 
demonstrated that 10-20 cm2 of gyral cortex is commonly required to generate scalp-
recognisable inter-ictal spikes. The phenomenon of temporal and spatial summation may 
explain the general relationship between frequency and amplitude. Oscillations with higher 
frequency are more liable to strict synchronisation between adjacent PSPs to produce high 
amplitudes recorded from a distant localisation leading to lower amplitudes compared to 
oscillations with lower frequencies (Singer, 1993; Schaul, 1998a; Pfurtscheller and da Silva, 
1999; Smit et al., 2006). The physiological basis for oscillatory EEG behaviour, for example 
the underlying time constants responsible for specific frequency ranges, is poorly understood 
although several mechanisms have been proposed (Pedley TA, Traub RD, 1990; Nunez et 
al., 2001). 
Epileptogenesis 
Hypersynchrony is probably a crucial factor of epileptogenesis and may involve either 
excitatory or recurrent inhibitory innervation (Binnie and Stefan, 1999c). Neither bursting 
nor synchrony depends, however, on synaptic transmission, as synchronous bursting can also 
be demonstrated in tissue slices after complete synaptic blockade, presumably on the basis of 
ephaptic transmission. In idiopathic generalised epilepsy (IGE) it is understood that the 
cortex is abnormally and unevenly hyperexitable and responds by spike-wave activity to 
essentially physiologic afferents from the thalamus and reticular-activating system, while the 
associated subcortical component becomes secondarily involved in the thalamocortical 
oscillations that maintain the discharge (Avoli and Kostopoulos, 1982; Koutroumanidis and 
Smith, 2005). Long-term potentiation by high frequency stimulation and the converse 
process for long-term depression  are the most studied models for memory formation in 
mammals (Cooke and Bliss, 2006). The long-term potentiation mechanism of memory is 
similar to the mechanism underlying focal epileptogenesis by kindling (Meador, 2007). 
Kindling involves repeated administration of brief, low-intensity trains of electrical stimuli 
that result in a permanent state of increased susceptibility and even spontaneous seizures. 
The hippocampus contributes both through its role in memory formation and its low seizure 
threshold. Transition from normal to epileptiform behaviour of neuronal networks is 
probably caused by greater spread and neuronal recruitment secondary to a combination of 
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enhanced connectivity, enhanced excitatory transmission, a failure of inhibitory 
mechanisms, and changes in intrinsic neuronal properties (Duncan et al., 2006). 
4.1.3 Basic elements of visually assessed EEGs 
Visual EEG assessment can be separated into several specific elements. Each element has its 
own significance, but usually all elements, together with clinical information, should be 
brought together to draw a conclusion. 
The EEG background activity (BA) is defined as any EEG activity representing the setting in 
which a given normal or abnormal pattern appears and from which such a pattern is 
distinguished (Chatrian et al., 1983). The alpha rhythm (AR) is a separate part of the BA. 
The AR is defined as the dominant posterior rhythm with frequency 8–13 Hz that is blocked 
or attenuated by eye opening. Alpha variant rhythm is defined as with AR characteristics but 
with frequency outside the 8–13 Hz alpha band (Chatrian et al., 1983). We defined the BA 
apart from the AR (or AR variant) as the general background activity (GBA). Low GBA 
frequency and high GBA amplitude are generally interpreted as EEG background slowing 
and is indicative of CNS pathology (Dustman et al., 1993; Babiloni et al., 2006). Most of the 
cerebral activity observed in the scalp EEG falls in the range of 1-20 Hz. EEG activity is 
separated into frequency bands; delta (< 4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (>13 
Hz, usually 13-40 Hz). 
EEG findings occur as normal or abnormal patterns appearing from, and distinguished from, 
the BA. The EEG findings can be separated into four groups: Epileptiform pathology, non-
epileptiform pathology, normal findings and variants, and extra cerebral activity. 
4.1.4 Factors affecting EEG activity 
EEG activity can be affected by numerous endogenous and exogenous factors. Age, and 
thereby the maturation of the brain, is crucial for the appearance of EEG activity. 
Knowledge about the normality at different ages is essential to separate pathology from 
normality. In general, there are slower frequencies and higher amplitudes found in EEGs 
from children compared to EEGs from adults. When it comes to pathology, a usual effect in 
adult EEGs is the reappearance of slow activities, appearing diffusely in general pathology 
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and localised in focal pathology. Consciousness, the degree of alertness, sleep-wake cycles, 
and drugs acting in the brain are furthermore critical for the appearance and assessment of 
the EEG. 
4.1.5 EEG techniques 
Long term monitoring (LTM) 
Some diagnostic problems cannot be adequately addressed by inter-ictal routine EEG 
recordings, but require monitoring over a long period of time lasting for hours to weeks. If 
the visual inspection of clinical events is presumed to be essential, EEG with synchronous 
digital video-monitoring is to prefer, otherwise ambulatory EEG with a portable recording 
and storage unit is suitable. The clinical applications of EEG monitoring are: 
• diagnosis of paroxysmal neurological attacks 
• differentiation between nocturnal epilepsy and parasomnias 
• diagnosis of psychogenic non-epileptic seizures 
• characterisation of seizure type 
• quantification of inter-ictal epileptiform discharges or seizure frequency 
• evaluation of candidates for epilepsy surgery (Smith, 2005). 
Amplitude-integrated EEG (aEEG) 
aEEG is a LTM technique where the EEG data recorded with a reduced number of 
electrodes is visualised as a time-compressed amplitude-integrated trend measure. aEEG has 
become increasingly acknowledged as a method for continuous evaluation of brain function 
in neonates (Hellstrom-Westas and Rosen, 2006). One reason for this was the finding that 
the very early background pattern is sensitive for predicting outcome in asphyxiated full-
term infants even during the first postnatal hours (Hellstrom-Westas et al., 1995; Eken et al., 
1995). aEEG has also proved to predict outcome after cardiac arrest and induced 
hypothermia in an adult population (Rundgren et al., 2006). 
 17
Intracranial EEG 
Intracranial EEG recordings are performed in the presurgical evaluation of patients with 
drug-resistant focal epilepsy where non-invasive techniques have not been able to locate the 
epileptogenic zone. Implanted subdural electrodes allow recording from large superficial 
cortical areas, but provide limited coverage of deep-seated structures, such as the 
hippocampus, as well as of the cortex within sulci (Cossu et al., 2005). Stereotactically 
inserted intracerebral electrodes have the advantage of excellent sampling from mesial 
structures and from intrasulcal cortex, but with the disadvantage of providing information 
from a limited volume of tissue. Such electrocortigography is used peroperatively to identify 
the location and borders of the epileptogenic area, to guide the extent of resection, and to 
secure its completeness (Kuruvilla and Flink, 2003). 
EEG source imaging 
EEG source imaging attempts to visualise the origin of scalp EEG recordings. This 
represents “the inverse problem”. EEG can only measure the electrical dipole current 
components perpendicular to the surface where it is measured. The EEG signal reflects the 
sum of the electrical dipoles from the recorded tissue. The dipoles located near the surface 
contribute more than the distant ones. Only synchronized electrical activities sum up, 
whereas non-phase locked sources may cancel each other out and contribute only as 
statistical fluctuations (i.e., imperfect cancellation) to the EEG (Ritter and Villringer, 2006). 
The exact relation between intracranially and extracranially recorded epileptiform activity, 
however, has been the subject of considerable debate (Lantz et al., 2003). Numerous models 
have been applied to solve the inverse problem, but by introducing reasonable a priori 
constraints EEG source imaging can be a useful tool (Michel et al., 2004). 
4.1.6 EEG applications 
Even though epilepsy is a clinical diagnosis, EEG plays a major role in evaluating epilepsy, 
the single most studied patient diagnosis in nearly all EEG laboratories, and the area in 
which EEG is of greatest clinical value (Binnie and Stefan, 1999b; Flink et al., 2002a). Such 
investigations serve three main purposes: to support the general diagnosis of epilepsy, to aid 
deciding if the seizure is generalized or focal, and to aid syndrome classification (Binnie and 
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Stefan, 1999a; Fowle and Binnie, 2000). Despite advances in neuro-imaging techniques over 
the past three decades that have helped identifying structural lesions of the central nervous 
system, EEG continues to provide valuable insight into brain function by demonstrating 
nonepileptiform focal or diffuse abnormalities and epileptiform abnormalities (Markand, 
2003). EEG facilitates differentiating between epileptic and non-epileptic seizures, seizure 
types, epilepsy syndromes, focal or generalised epilepsies, and symptomatic versus 
idiopathic epilepsies. Thereby EEG also facilitates the choice of antiepileptic medication and 
prediction of prognosis. EEG is furthermore useful in the evaluation of focal and diffuse 
encephalopathies, comatose conditions and cerebral disorders affecting neonates and infants 
(Markand, 2003). 
Quantitative EEG (qEEG) 
The most commonly used quantitative representation of EEG is the estimation of power 
density of selected EEG frequency bands Fast Fourier Transform (Barry et al., 2003). The 
EEG is usually first visually inspected, and a period with a minimum of artefacts is chosen. 
The frequency range has traditionally been transformed into delta (1.5-3.5 Hz), theta (3.5-7.5 
Hz), alpha (7.5-12.5 Hz), and beta (12.5-20 Hz). Results from each electrode can be 
represented as absolute power in each band (total μV2), relative power in each band 
(percentage of total power), coherence (a measure of synchronisation between activity in 
two channels), or symmetry (the ratio of power in each band between a symmetrical pair of 
electrodes) (Hughes and John, 1999). 
4.1.7 Functional neuroimaging 
MRI/fMRI 
MRI is the mainstay of brain imaging in elective clinical practice, and should be used in all 
patients who develop epilepsy as adults, in whom focal onset is suspected, or in whom 
seizures persist (Duncan et al., 2006). An increase of neuronal activity is accompanied by an 
increase of the metabolic rate of oxygen consumption and a much larger increase in the local 
blood flow. This result in a change in the proportion of oxygenated vs. deoxygenated 
haemoglobin and thereby a change of magnetic properties. These principles are exploited in 
the fMRI blood-oxygen-level-dependent (BOLD) contrast technique. Simultaneous fMRI 
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and EEG is being investigated for its possibilities of combining the high temporal 
millisecond resolution of EEG with the high spatial resolution of fMRI. When the temporal 
pattern from events such as epileptiform discharges is known, fMRI may provide an 
anatomical map of the corresponding physiologic activity with a spatial resolution of less 
than 5 mm3 (Stern, 2006; Benar et al., 2006). The most widely used technique for such 
integration is spike-triggered imaging. However, both theoretically and empirically there 
will be situations where fMRI signals occur without any EEG correlates and vice versa. The 
mismatch between electrophysiological and haemodynamic signals provide challenges for 
the integration of EEG and fMRI (Ritter and Villringer, 2006). 
Magnet encephalography (MEG) 
The MEG-technique measures oscillations of the magnetic fields arising arise from the same 
sources in the brain as in EEG (Sharon et al., 2007). The signals are recorded from sensors 
outside the scalp, and share the same high temporal millisecond resolution as in EEG. 
Magnetic fields are insensitive to tissue connectivity differences, resulting in simpler 
calculations of the reverse problem compared to EEG, which in turn increases localisation 
accuracy (Rampp and Stefan, 2007). Each electrical current will produce a magnetic field 
perpendicular to the electrical current. The EEG and MEG techniques are thus 
complementary, and the combination of the two could yield the most accurate localisation 
(Sharon et al., 2007). 
Cerebral blood flow tracers 
Positron emission tomography (PET) 
PET has been an important tool in the mapping of all aspects of brain function, not just 
neuronal activation, and depending on the agent used (Savoy, 2001). PET scanning utilizes 
an exogenously administered agent that is tagged with a positron emitter, usually with a very 
short half-life. An emitted positron will travel a short distance, and as it collides with an 
electron two high-energy gamma rays are emitted that travel in exactly opposite directions 
(Shin, 2000). The coincident detection of this pair of photons on opposite sides of the head, 
thus defining a line along which is the likely source of the gamma rays, forms the basic data 
for PET (Savoy, 2001). 
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Single photon emission tomography (SPECT) 
SPECT uses a principle similar to that of PET, but the radioactive isotope used in SPECT 
emits only a single photon, and so the localisation of the photon cannot be calculated as a 
pair as in PET scan. This results in a lower spatial resolution (Shin, 2000). The radioactive 
isotope used is, however, much easier available and has a longer half-life, making SPECT 
the only modality, except for EEG, practically suited for imaging brain activity changes 
during a spontaneously occurring seizure (Knowlton, 2006). Subtracting inter-ictal SPECT 
from ictal SPECT and co-registered with MRI has further improved the ability of localising 
the seizure focus in patients with partial epilepsy (O'Brien et al., 1998). 
Transcranial magnetic stimulation (TMS) 
Transcranial magnetic stimulation (TMS) is a method for activating the brain by modulating 
the voltage over the cell membrane of cortical neurons. This is performed by applying 
magnetic fields generated by short current pulses driven through a coil, which is placed 
against the subject's head (Barker and Jalinous, 1985). The transient magnetic fields induce 
corresponding electrical fields in the tissues of the head, thus stimulating cortical neurons. 
The main critical issue of the TMS technique has been the precise and reliable positioning of 
the applied magnetic field according to the cortical region of interest (Schonfeldt-Lecuona et 
al., 2005; Sparing et al., 2008). This problem is addressed through newly introduced 
stereotactic neuronavigational strategies according to the subject’s MRI, fMRI, or the use of 
functional neuroimaging data from the literature, a so-called “probabilistic approach”. 
Stimulation of different cortical areas evokes remote EEG activity. The recently combined 
use of TMS and EEG has provided means for the detailed study of the reactivity of any 
cortical region in the intact brain; also the reactivity of non-motor cortical areas related to 
higher-order functions (Komssi and Kahkonen, 2006). 
4.1.8 Future EEG applications 
The temporal millisecond resolution of EEG (and MEG) studying cerebral neuronal activity 
is unique and can never be achieved by the techniques based on indirect measurements such 
as altered cerebral metabolism, O2 consumption, or blood flow (Ebersole, 2000). Other 
imaging techniques, however, provide far better spatial resolution with millimetre accuracy. 
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Thus, future applications will probably to a greater extent combine EEG data with imaging 
techniques with higher spatial resolution. 
Independent component analysis (ICA) is a statistical method to extract independent signals 
from a linear mixture of sources (Comon, 1994). As long as the EEG can be considered a 
linear mixture of electric brain activities, ICA might be able to isolate those activities. A 
joint ICA model combining the high temporal resolution of EEG with the spatial resolution 
of haemodynamic activation has recently been proposed as a promising general framework 
of combining multiple modalities (Eichele et al., 2005; Moosmann et al., 2007; Eichele et 
al., 2007). 
Brain computer interface provides communication between neural activity and external 
devices. The most widely applied and advanced current use of brain computer interface is 
the cochlea implants, bringing the perception of sound to thousands of deaf individuals by 
means of electrodes implanted in the cochlea. Similar attempts are under way to provide 
images to the visual cortex and to allow the brains of paralyzed patients to control the 
external environment via recording electrodes (Mussa-Ivaldi and Miller, 2003). 
4.2 Epilepsy 
Epilepsy is a disorder characterized by spontaneous recurrent episodes of paroxysmal brain 
dysfunction due to a sudden, disorderly, and excessive neuronal discharge (Adams et al., 
1997). The incidence of epilepsy in developed countries is around 50 per 100 000 people per 
year, and is higher in infants and elderly people (MacDonald et al., 2000; Sander, 2003; 
Forsgren et al., 2005; Duncan et al., 2006). Epilepsy lifetime prevalence is 4-6 per 1000 
(MacDonald et al., 2000; Kelvin et al., 2007). 
4.2.1 Etiology 
Most commonly epilepsies probably represent complex traits with environmental effects 
acting on inherited susceptibility, mediated by common variation in particular genes 
(Duncan et al., 2006; Meador, 2007). Reported etiological factors for epilepsy are listed in 
Table 1 (from (Forsgren et al., 2005). 
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Table 1 
Estimated proportions (%) of presumed causes of epilepsy in population-based incidence studies. 
    
Range 
(%) 
Vascular 14-21 
 Ischemia 16-18 
 Haemorrhage 3-4 
Trauma 0-16 
Neoplasm 6-10 
Infection 0-2 
Degenerative 1-5 
Congenital 4-7 
Other 0-13 
Remote or progressive symptomatica 31-56 
Unknown 44-69 
aSummary of all etiologies mentioned above. 
 
4.2.2 Diagnosis and classification 
There are two dichotomies dividing the epilepsies and epileptic syndromes into main 
categories; generalised versus localisation-related, and idiopathic versus symptomatic 
(Commission on Classification and Terminology of the International League Against 
Epilepsy, 1989; Wolf, 2006). Generalised epilepsies comprise widespread morphological or 
functional pathology. Genetic factors causing, for example, channelopathies are presumed to 
have a major causative role in the development of seizures (Pitkanen et al., 2007). 
Localisation-related epilepsies and syndromes are epileptic disorders in which seizure 
semiology or findings at investigation disclose a localised origin of the seizures. The lesion 
can be genetically programmed cellular alterations like neuronal migration disorders in the 
cortex, or an acquired lesion like traumatic brain injury or stroke. Epilepsies are furthermore 
categorised into epileptic syndromes on the basis of age, type of seizures and EEG findings 
(Commission on Classification and Terminology of the International League Against 
Epilepsy, 1989). 
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Epilepsy is a clinical diagnosis, but EEG and brain imaging techniques play a major role in 
evaluating epilepsy (Flink et al., 2002b; Duncan et al., 2006). Persistent focal epileptiform 
activity suggests localisation-related epilepsy whereas generalised epileptiform activity 
suggests generalised epilepsy (Pillai and Sperling, 2006). Non-epileptiform pathology 
suggests symptomatic etiology whereas the idiopathic epilepsies usually have normal BA. 
The 3/sec spike-slow-wave activity is the hallmark of idiopathic epilepsy whereas similar 
activity with lower frequency is associated with symptomatic generalised epilepsies. 
Imaging techniques can visualise structural lesions underlying symptomatic epilepsies. Such 
investigations are especially important in individuals with refractory partial seizures who 
would be possible candidates for surgical treatment, and in those with progressive 
neurological or psychological deficits (Duncan et al., 2006; Commission on Neuroimaging 
of the International League Against Epilepsy, 2008). 
4.3 Databases 
A database is a filing system organised to provide fast access to desired pieces of data, the 
term being mostly used for computerised systems. The development of the computer 
industry has dramatically increased the possibilities of generating and collecting data, and 
likewise the need of appropriate data storage and retrieval. Modern databases address these 
challenges, and provide tools for personal needs, laboratory solutions, as well as for large 
scale multidisciplinary database applications. Storing data in a well organised database thus 
provides a powerful tool for clinical, educational and scientific purposes. 
Different areas within human science have exploited these new possibilities to a variable 
extent. The field of genomics has embraced information technology much more effectively 
than neuroscience (Koslow, 2000). The Human Genome Project is a successful example 
(Collins and McKusick VA, 2001). Geneticists agreed long ago on the value of storing 
reproducibly generated DNA sequences, but not images of their sequencing gels (Chicurel, 
2000). This illustrates the problem of complex data structures. Electrophysiological data 
comprises a wide variety of large and complex data sets, and there is no widely accepted 
standard way for the data to be stored or described (French and Pavlidis, 2007). Consensus 
on what should be including in databases is needed. In addition, the technical difficulty of 
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collating and relating such disparate types of information must be solved to be able to 
globally share the data (Chicurel, 2000).  
Progress in neuroscience might be faster if researchers shared their results in a network of 
databases (Chicurel, 2000; Koslow, 2000). The Human Brain Project, the neuroscience 
counterpart of the Human Genomic Project, has been a major principal funding source for 
such initiatives (Huerta et al., 1993; Shepherd et al., 1998; Van Horn JD et al., 2004). A 
number of scientific journals have now mandated that authors of accepted papers are willing 
to provide access for other scientists to the raw data upon which the paper was based (Van 
Horn JD et al., 2004; Gordon E and Konopka LM, 2005). 
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6. Aims of the study 
I. To develop a new computerised EEG annotation system and then to build a database 
of EEG findings. 
II. To study the age-related development of the EEG BA. 
III. To study the age-related topographical tendency of expressing epileptiform activity. 
IV. To study the age-related occurrence of specific generalised epileptiform activity 
(GEA) features and GEA subtypes, and to study the correlation between specific 
GEA features. 
V. To study the effect of epileptiform activity on the EEG BA. 
VI. To study the effect of specific features of GEA on the EEG BA. 
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7. Materials and methods 
7.1 Platform and software 
The digital EEG software Nervus® has 3 main components: the `study room', the recorder 
and the editor. This software was used for all EEG recordings. Using the ‘study room’, one 
can schedule and record EEG tests, review, mark and annotate them and review patients' 
records stored in individual folders. With this EEG software as a core I developed the EEG 
annotation system (EAS) including 3 main components; the database module (DM) for data 
storage, the annotation module (AM) for visual EEG analysis, and the report generator 
module (RGM). The DM was developed using Microsoft Access, the AM using Microsoft 
Visual Basic programming language, and the RGM using Visual Basic and Visual Basic for 
Applications. 
7.2 Inter-system communication 
Direct input to the EAS from the EEG editor was initially accomplished by Windows 
Application Programming Interface (API) calls. Output to the EEG editor was executed by 
sending keystrokes from the annotation module to the editor. In a later version, the Nervus® 
software provided a more comprehensive Component Object Model (COM) interface, 
permitting all communication between the Nervus software and the EAS to be replaced by 
this technology (Microsoft, 2008) (Fig. 1). The DM was also linked to the hospital's patient 
administrative system using an open database connectivity (ODBC) link to an ORACLE 
database. 
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Fig. 1. Overview of the EEG annotation software (EAS) and its communication with the Nervus® EEG system 
including Nervus EEG editor, Nervus StudyRoom Database (a database connected to the Nervus EEG editor), 
and the hospital’s patient administrative system. COM: Component Object Model, ODBC: Open Database 
Connectivity, MS: Microsoft®
7.3 Standards 
EEG waveforms and activities were in our work categorized according to the American 
Society for Testing and Materials; ASTM (1994) standard (Table 2). These categories were 
further divided into 4 groups: `epileptiform pathology', `nonepileptiform pathology', `normal 
variants', and `extra-cerebral activity' (Westmoreland and Klass, 1990). A single waveform 
category could be placed in more than one of the 4 groups; for example the category `sharp 
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waves' was simultaneously placed in the groups `epileptiform pathology', `non-epileptiform 
pathology', and `normal variants' because a sharp wave could comply with all these 
characteristics. Some of the ASTM categories were omitted because they could be replaced 
by another category combined with parameters for localization or pattern. A few new 
categories were added (Table 2). Epileptic seizures were categorized according to the 
`Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic 
Seizures' (Commission on Classification and Terminology of the International League 
Against Epilepsy, 1981). International Classification of Diseases, Ninth Revision (ICD-9) 
was initially used for coding EEG related patient diagnoses, i.e. the reason for referral to 
EEG. This ICD-9 coding was, however, replaced by the International Classification of 
Diseases, Tenth Revision (ICD-10), which was used during the study period. 
Table 2 
Categorization of EEG waveforms/activity based on the ASTM ‘Standard specifications for transferring digital 
neurophysiological data between independent computer systems’ and with a few categories added (marked 
with an asterix). All categories are further divided into 4 groups: ‘epileptiform pathology’, ‘non-epileptiform 
pathology’, ‘normal variants’, and ‘extra-cerebral activity. 
Code Mother 
Code 
Description 
1  Epileptiform Pathology 
1.D 1 Sharp Appearing Activity Identifiers 
1.D.30 1.D Unspecific epileptiform discharges 
1.D.31 1.D Sharp transients 
1.D.41 1.D Sharp waves 
1.D.42 1.D Spikes 
1.D.43 1.D Polyspikes 
1.D.44 1.D Spike and wave complexes 
1.D.45 1.D Poly spike and wave complexes 
1.D.46 1.D Atypical spike and wave complexes 
1.D.47 1.D Sharp and slow wave complexes 
1.D.49 1.D Hypsarrhythmia 
1.F 1 Periodic/Rhythmic Cerebral Activity Identifiers 
1.F.11 1.F Beta activity 
1.F.12 1.F Alpha Activity 
1.F.14 1.F Theta activity 
1.F.16 1.F Delta activity 
1.G 1 Suppressions 
1.G.58 1.G Bursts with suppressions 
1.G.581 1.G Suppression/desynchronisation*
1.H 1 Eye-related Activity Identifiers 
1.H.68 1.H Photoparoxysmal activity 
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2  Nonepileptiform Pathology 
2.B 2 Background and Slow Wave Activity Identifiers 
2.B.11 2.B Beta activity 
2.B.12 2.B Alpha activity 
2.B.13 2.B Mu activity (continuous asymmetric) 
Code Mother 
Code 
Description 
2.B.14 2.B Theta activity 
2.B.16 2.B Delta activity 
2.B.19 2.B Slow fused transients 
2.B.191 2.B Hyperventilation response (pathological) *
2.B.1A 2.B Intermittent rhythmic delta activity (FIRDA etc) 
2.D 2 Sharp Appearing Identifiers 
2.D.31 2.D Sharp transients 
2.D.34 2.D Zeta waves 
2.D.35 2.D Triphasic waves 
2.D.41 2.D Sharp waves 
2.D.46 2.D Atypical spike and wave complexes 
2.G 2 Suppressions 
2.G.58 2.G Bursts with suppressions 
2.G.581 2.G Suppression/desynchronisation*
3  Normal variants 
3.A 3 Sleep and Wake Stage Identifiers 
3.A.01 3.A Unstageable activity 
3.A.02 3.A Stage W (wake) activity 
3.A.03 3.A REM sleep activity 
3.A.04 3.A REM-spindle activity 
3.A.05 3.A Stage I sleep activity 
3.A.06 3.A Stage II sleep activity 
3.A.07 3.A Stage III sleep activity 
3.A.08 3.A Stage IV sleep activity 
3.A.09 3.A Alpha-delta sleep activity 
3.A.091 3.A Drowsiness*
3.A.092 3.A Trace alternant*
3.B 3 Background and Slow wave Activity Identifiers 
3.B.11 3.B Beta activity 
3.B.12 3.B Alpha activity 
3.B.13 3.B Mu activity 
3.B.14 3.B Theta activity 
3.B.141 3.B Occipital slow waves of youth*
3.B.16 3.B Delta activity 
3.B.19 3.B Slow fused transients 
3.B.191 3.B Hyperventilation response (normal)*
3.B.1A 3.B Intermittent rhythmic delta activity 
3.C 3 Sleep Activity and Event Identifiers 
3.C.20 3.C Sleep activity 
3.C.21 3.C Sleep spindles 
3.C.22 3.C V waves (vertex sharp transients) 
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3.C.23 3.C F waves 
3.C.24 3.C K complexes 
3.C.25 3.C Positive occipital sharp transients (POSTS) 
3.C.26 3.C Saw tooth waves 
3.C.27 3.C Sleep stage shifts 
3.C.28 3.C Arousals 
3.C.29 3.C Awakenings 
3.D 3 Sharp Appearing Identifiers 
3.D.31 3.D Sharp transients 
3.D.32 3.D Wickets 
3.D.33 3.D Small sharp spikes 
3.D.34 3.D Zeta waves 
3.D.36 3.D Phantom spike and wave activity 
3.D.37 3.D 14 and 6 Hz positive bursts 
3.D.38    3.D Lambda waves 
Code Mother 
Code 
Description 
3.D.39 3.D Rhythmic theta of drowsiness 
3.D.3A 3.D Subclinical rhythmic electrographic discharge of adults 
3.D.41 3.D Sharp waves 
3.G 3 Suppressions 
3.G.581 3.G Suppression/desynchronisation*
3.H 3 Eye-related Activity Identifiers 
3.H.66 3.H Photic driving activity 
4  Extracerebral activity 
4.H 4 Eye-related Activity Identifiers 
4.H.60 4.H Unspecific eye movements 
4.H.61 4.H Eye blinks 
4.H.62 4.H Nystagmoid eye movements 
4.H.63 4.H Slow eye movements 
4.H.64 4.H Fast irregular eye movements 
4.H.65 4.H Rapid eye movements 
4.H.67 4.H Photomyogenic activity 
4.H.69 4.H Electroretinogram 
4.I 4 Myogenic Noncerebral Activity Identifiers 
4.I.70 4.I Unspecified myogenic activity 
4.I.72 4.I Myokymia 
4.I.73 4.I Facial synkinesis 
4.I.74 4.I Hemifacial spasms 
4.I.75 4.I Extraocular muscle activity 
4.I.76 4.I Tremor activity 
4.I.77 4.I Myoclonic activity 
4.I.78 4.I Periodic movements of sleep 
4.I.79 4.I Periodic movements of sleep with arousals 
4.J 4 Artefactual Activity Identifiers 
4.J.80 4.J Unspecified artefacts 
4.J.81 4.J Electrode/instrumental artefacts 
4.J.82 4.J Movements artefacts 
 32
4.J.83 4.J Sweat or galvanic skin artefacts 
4.J.84 4.J Pulse artefacts 
4.J.85 4.J EKG artefacts 
4.J.86 4.J Respiratory artefacts 
4.J.87 4.J Glossokinetic artefacts 
4.J.88 4.J Swallowing/chewing/sucking artefacts 
4.J.89 4.J External interference artefacts 
4.K 4 Special Respiratory and Cardiovascular Event Identifiers 
4.K.90 4.K Unspecified cardiorespiratory events 
4.K.91 4.K Apneas or hypopneas with ventilatory effort 
4.K.92 4.K Apneas or hypopneas with little or no ventilatory effort 
4.K.93 4.K Oxygen desaturations 
4.K.94 4.K Sinus dysrhythmias 
4.K.95 4.K Sypraventricular dysrhythmias 
4.K.96 4.K Ventricular dysrhythmias or asystoles 
4.K.961 4.K Normal one channel ECG*
4.K.97 4.K Systolic hypotensive episodes 
4.K.98 4.K Diastolic hypotensive episodes 
 
7.4 EEG recordings 
All routine EEGs recorded at Haukeland University Hospital from March 1st 2000 to 
December 31st 2005 were visually evaluated and described using the EAS. This included 
17 723 EEGs from 12 511 patients. Long-term registrations, EEGs during general 
anaesthesia, and during Wada tests and Tilt tests were not included in this study (Wada and 
Rasmussen, 1960; Low et al., 1983). 
Paper II included the first EEG from consecutive patients recorded from March 1st 2000 to 
March 1st 2002 comprising 4651 EEGs from 2228 females and 2423 males. 
Paper III included the first EEG containing focal epileptiform activity (FEA) from 
consecutive patients recorded from March 1st 2000 to December 31st 2005 comprising 1647 
EEGs from 852 females and 795 males. 
Paper IV recruited patients from patients recorded from March 1st 2000 to December 31st 
2005. Critically ill patients were excluded due to the lack of consensus regarding the 
assessment of rhythmic and periodic EEG patterns encountered in this group (Hirsch et al., 
2005). EEGs with suppression-burst complexes, triphasic waves and paroxysmal flattening 
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can in some cases appear as an epileptiform phenomenon but were excluded in this study 
due to the controversy about the nature and etiology of such activity (Raegrant et al., 1991; 
Husain et al., 1999). The first EEG containing GEA from each patient was selected for this 
study. EEGs marked in routine coding as having GEA were re-evaluated. 325 EEGs, 181 
from females and 144 from males, were found to have GEA. These 325 EEGs were scored 
for the following GEA features: Waveform, bilateral synchronicity, regularity, frequency, 
amplitude of the sharp component, photoparoxysmal response (PPR), and hyperventilation 
sensitivity (HVS). 
In paper III and IV a control group consisting of all first EEGs from drug-free outpatients 
with no EEG pathology from the study period were included (N = 3268). 
7.5 Statistics 
In paper II and III age-related amplitude and frequency variation were described using 
polynomial regression models with age as the independent variable. Multivariate polynomial 
models were applied where 3 or more variables were included in the model at the same time. 
For some of the tests, the number of individuals at high age was low. The polynomial 
models therefore became unstable. Individuals above the age of respectively 85 and 60 years 
in publication II and III were excluded from these polynomial regression analyses. The chi-
square test was used to test age dependency for the localisation of FEA in topographical 
regions as well as for FEA asymmetry and for association between the EEGers and 
asymmetry. S-Plus 6.0 and SPSS 13.0 were used for the analyses. 
In paper IV continuous and binomial dependent variables were described using multiple 
linear and logistic fractional polynomial regression models, respectively (Royston and 
Sauerbrei, 2005). Age-related changes in the occurrence of specific GEA-types were 
described using multinomial logistic regression analysis. Pairwise correlation analyses were 
calculated with Spearman’s correlation test. Stata 9.2 was used for the analyses. 
 
 34
8. Results 
8.1 Paper I 
8.1.1 EEG annotation 
Each EEG was analysed visually by the EEGer according to standard procedures. The 
current EEG test in the editor was automatically linked to the corresponding description in 
the description module. All patient demographic data and administrative test parameters 
were thereby set directly. Start and stop of events later to be described were manually 
marked in the EEG editor. From the referral, the interpreter set one or more relevant ICD-10 
diagnoses. The interpreter could simultaneously see a table with all previous hospital 
diagnoses for this patient. 
EEG background activity (BA) 
The alpha rhythm was evaluated for frequency, amplitude, asymmetry, and reactivity (Fig. 
2). The frequency and amplitude range were drawn graphically with the mouse and could 
thereby be determined in one operation. Numerical values were automatically denoted in 
separate boxes. If asymmetric, the amplitude could be set separately for the left and right 
side. Reactivity was marked by clicking `suppressed by eye opening'. 
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Fig. 2. Input interface for alpha rhythm (AR), frequency along the X-axis, amplitude along the Y-axis. 
The BA was described for frequency and amplitude and was marked graphically in the same 
way as the alpha rhythm (Fig. 3). As recommended in `Guidelines for writing EEG reports' 
(American Electroencephalographic Society, 1994), the frequency was given in Hertz and 
the amplitude in micro volts, both with the possibility of describing a range of values. 
Several different rhythms that together constituted the BA could be marked separately. If 
this activity was focal or asymmetric, it was marked as an EEG event rather than as BA. BA 
was defined as any activity representing the setting in which a given normal or abnormal 
pattern appears and from which such a pattern was distinguished (Chatrian et al., 1983). 
However, the alpha rhythm or alpha variant rhythm was described separately, as mentioned 
previously, because the impact of this specific rhythm differs from the rest of the BA. For 
instance a 7 Hz rhythm has a completely different meaning if it represents the alpha variant 
rhythm or if it is part of the non-alpha BA. 
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Fig. 3. Input interface for general background activity (GBA), frequency along the X-axis, amplitude along the 
Y-axis. 
EEG findings 
The description module automatically picked up EEG fragments already marked (see 
above). All such fragments were categorized by clicking the suitable category (Fig. 4). By 
clicking an event in the description module, the EEG editor automatically navigated to the 
corresponding part of the EEG. The waveform/activity categories were arranged in a 
hierarchical tree view with the 4 main groups: `epileptiform pathology', `non-epileptiform 
pathology', `normal variants', and `extra-cerebral activity' as the main branches. The 
interpreter could in addition grade the probability of epileptogenic origin as `definite', 
`probable', or `possible'. Activity branched as `non-epileptiform pathology' could still be 
characterized as `epileptogenic origin not excluded'. To provide data consistency, this 
grading of epileptogenic probabilities was restricted to categories that could possibly be 
epileptogenic. The localization of the EEG activity was determined by clicking the traces 
where the EEG event occurred. In the monopolar montage, the corresponding electrode was 
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directly marked, whereas in bipolar montages, the system automatically determined the 
electrodes engaged on the basis of the marked traces. Maximum localization could similarly 
be marked. According to the electrodes engaged, the system proposed `no asymmetry', `mild 
asymmetry', `moderate asymmetry', `marked asymmetry', or `left/right side only'. This 
grading could be overruled by the interpreter, with the exception of `left/right side only'. 
Each event could be quantitatively determined as `rare', `intermittent', `frequent', or 
`continuous'. The event pattern could be evaluated as `scattered', `paroxysmal', `rhythmical', 
or `periodical'. A free text annotation could be attached to any EEG event. 
Events marked from the EEG editor could also be defined as a seizure. Seizures were further 
classified according to the international classification system, presented in a tree-view 
structure like the EEG waveform/activity classification table (see above). Free text 
description could be attached to all seizure events. 
Fig. 4. Input interface for describing EEG events/findings. Waveform/activity categories are organized in a tree 
view (A). EEG findings are supplied with quantity- (B), pattern- (C), and asymmetry- (D) identifiers. Traces 
clicked by the interpreter are marked with a `V'. Electrodes engaged are automatically marked as red. 
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8.1.2 Report generator 
After completing the EEG description, the system generated a report from the information 
collected in the database (Fig. 5). The report was made as a MS Word document that could 
be edited directly and was automatically saved and linked to the EEG recording. The main 
conclusion was based on the EEG events described. A pathological EEG was defined as a 
test that contained events of either `epileptiform pathology' or `non-epileptiform pathology'. 
This proposal for a conclusion made by the system was not itself a part of the database, but 
produced as a syntax of the database information. The conclusion could be edited and 
corrected by the EEGer. Finally, the EEGer was supposed to manually fill in an overall 
assessment in light of the clinical question. During the recording session, the EEG nurse or 
technician filled in `test notes', `patient notes' and `medication' in the EEG recorder. This 
information was automatically transferred to the report. If the marked events occurred during 
a period of hyperventilation or photo-stimulation, this was automatically noted by the 
system. The localization of all pathological findings was visualized on a head model with 
different patterns for epileptogenic and non-epileptogenic pathology (Fig. 5). 
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Fig. 5. EEG report generated from the EEG database. This report was generated automatically except from the 
last sentence where the EEGer filled in relevant clinical comments. 
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8.1.3 Search engine 
A search engine was developed to provide easy access to all the relevant variables in the 
database. The user was guided through a stepwise procedure choosing; the parameters to be 
viewed, criteria, and sorting order. This resulted in a structured query language (SQL)-string 
that was sent to the database. The patient's previous hospital diagnoses as well as the EEG 
referral diagnoses could be included in the query. The result was presented in a tree-view, 
where the EEG-test or EEG activity of interest could be chosen and the actual EEG opened.
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8.2 Paper II 
8.2.1 AR 
Estimated mean AR frequency increased gradually until age 20 years and to a value of 10 Hz 
(Fig. 6A). The frequency remained stable until age 45 years and then declined. Higher AR 
frequencies were recorded for females (P < 0.001) (Fig. 6B). AR frequencies were 
significantly higher for EEGs without non-AR pathology (P < 0.001), being less pronounced 
in children (Fig. 6C). Medication reduced the AR frequency (P < 0.001), most pronounced 
for patients with non-AR pathology (P interaction = 0.029). 
 
Fig. 6. AR frequency as a function of age for (A) all patients with registered alpha rhythm, each dot 
representing one patient, (B) females and males, (C) EEGs without and with non-AR pathology and without 
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and with medication, and (D) 4 different EEGers. The estimated means are based on a polynomial regression 
model of 7th order. 
Estimated mean AR amplitude declined from 50 μV in the very young to 30 μV at 35–40 
years of age (Fig. 7A). It then remained stable, except for a small increase in the very old. 
Females had higher AR amplitudes than males (P < 0.001), but not in children (Fig. 7B). The 
difference increased with age (P < 0.001). 
 
Fig. 7. AR amplitude as a function of age for (A) all patients with registered alpha rhythm, each dot 
representing one patient, (B) females and males, (C) EEGs without and with non-AR pathology and without 
and with medication, and (D) 4 different EEGers. The estimated means are based on a polynomial regression 
model of 5th order. 
8.2.2 GBA 
Delta activity never occurred in EEGs evaluated as normal in individuals over age 26 years. 
At age 15–25 years such activity occurred only rarely and then together with low amplitude 
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(Fig 8). For the 4–7 Hz GBA activity, the 95th percentile was below 31 mV at ages over 20 
years, and for the 8–11 Hz activity it was below 25 mV. 
 
Fig. 8. Relationship between GBA frequency, amplitude, and patient age in all EEGs evaluated as normal. The 
boxes indicate the 25th and 75th percentiles, lines within the boxes mark the median. Whiskers indicate the 
10th and 90th percentiles, and red circles indicate the 5th and 95th percentiles. 
Estimated mean GBA frequency increased from 3 Hz under the age of 5 years to 5 Hz at age 
30 years and with only a small decrease afterwards (Fig. 9A). EEGs with non-GBA 
pathology had lower GBA frequencies than those without (P < 0.001) (Fig. 9C). Medication 
significantly reduced the GBA frequency (P < 0.001). 
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Fig. 9. GBA frequency as a function of age for (A) all patients with registered GBA, each dot representing one 
patient, (B) females and males, (C) EEGs without and with non-GBA pathology and without and with 
medication, (D) 4 different EEGers. The estimated means are based on a polynomial regression model of 5th 
order. 
The estimated mean GBA amplitudes declined from 40 μV at birth to 15 μV at age 30 years 
from where it remained stable with a small increase over 70 years (Fig. 10A). EEGs with 
non-GBA pathology had higher amplitudes than EEGs without such pathology (P < 0.001) 
(Fig. 10C). Medication significantly increased the GBA amplitude (P < 0.001). 
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Fig. 10. GBA amplitude as a function of age for (A) all patients with registered GBA, each dot representing 
one patient, (B) females and males, (C) EEGs without and with non-GBA pathology and without and with 
medication, and (D) 4 different EEGers. The estimated means are based on a polynomial regression model of 
7th order. 
8.2.3 Agreement between EEGers 
The agreement between the EEGers in AR and GBA assessment showed significant (P < 
0.001) minor to moderate differences in absolute values, but always with the same trends for 
all EEGers (Fig. 6C, Fig. 7C, Fig. 9C, Fig. 10C). 
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8.3 Paper III 
8.3.1 FEA topographical distribution 
Topographical distribution of FEA was age-dependent for all brain regions (p < 0.0005) 
except for the temporal (p = 0.17) (Fig. 11). 
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Fig. 11. Age-related topographical distribution of FEA in 1647 consecutive patients with EEGs containing 
FEA. FEA could be located in more than one region. 
8.3.2 FEA asymmetry 
FEA lateralised more often to the left side of the brain compared to the right; 565 (34%) vs. 
487 (30%) (p = 0.018). 595 EEGs (36%) had no side asymmetry. The left–right result did 
not vary significantly between the 6 EEGers (p = 0.18). There was still more left than right 
FEA asymmetry when only EEGs with completely unilateral FEA were included; 444 vs. 
381 (27% vs 23%) (p = 0.031). Left and right FEA asymmetry varied significantly between 
age groups (p = 0.013) (Fig. 12). 
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Fig. 12. Side asymmetry of FEA in 1647 consecutive patients with EEGs containing FEA. 
 
Also FEA asymmetry independent of left or right side varied between age groups (p < 
0.0005). The relative risk for asymmetric FEA was highest in patients over the age of 80 
years (94 asymmetric vs. 7 symmetric), and lowest at age 20–39 years (171 asymmetric vs. 
80 symmetric) (Fig. 13). 
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Fig. 13. Probability of more than moderate FEA asymmetry independent of left or right side in different age 
groups, as compared to the age group 0–4 years where the probability is defined as 1. The middle mark shows 
the odds ratio, while the upper and lower marks define the 95% confidence interval. 
8.3.3 FEA and AR 
The total group of patients with FEA had lower AR frequency (p < 0.0005) and higher 
amplitude (p < 0.0005) compared to the drug-free outpatient controls (Fig. 14a and b). The 
subgroup of drug-free outpatients with FEA had lower AR frequency (p = 0.0041) and 
higher amplitude (p = 0.0023) compared to the outpatient controls (Fig. 14c and d). 
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Fig. 14. AR frequency (a) and AR amplitude (b) from all patients with FEA and from drug-free outpatient 
controls. AR frequency (c) and AR amplitude (d) from drug-free outpatients with FEA and from drug-free 
outpatient controls. 
8.3.4 FEA and GBA 
The total group of patients with FEA had lower GBA frequency (p < 0.0005) and higher 
amplitude (p < 0.0005) compared to the drug-free outpatient controls (Fig. 15a and b). The 
subgroup of drug-free outpatients with FEA had higher amplitude (p < 0.0005) compared to 
the outpatient controls, while GBA frequency was the same (p = 0.96) (Fig. 15c and d). 
 50
 
Fig. 15. GBA frequency (a) and GBA amplitude (b) from all patients with FEA and from drug-free outpatient 
controls. GBA frequency (c) and GBA amplitude (d) from drug-free outpatients with FEA and from drug-free 
outpatient controls. 
8.4 Paper IV 
8.4.1 GEA and BA 
All EEG background parameters were clearly affected in EEGs with GEA compared to 
controls, as shown in Figure 16 and Table 2. The effects of other GEA-related variables are 
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also shown in Table 2. 
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Figure 16 Fitted values for alpha rhythm (AR) amplitude (a), AR frequency (b), general background activity 
(GBA) amplitude (c), and GBA frequency (d) by age in 325 patients with generalised epileptiform activity 
(GEA) and in 3268 drug-free outpatient controls. Shaded areas are fitted values ± 1.96 SE. 
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Table 2 Association between GEA-related variables and EEG BA, measured as AR -and GBA amplitudes and 
frequencies. 
Study groups Independent variable 
Effect variable 
for EEG 
background 
activity 
Significance
↑ AR amp p < 0.001 
↓ AR freq p < 0.001 
↑ GBA amp p < 0.001 
GEA present 
↓ GBA freq p = 0.038 
↓ AR freq p = 0.002 
GEA patients (N = 325) 
and controls (N = 2368) 
Male gender 
↓ GBA freq p = 0.002 
'Polyspike' ↑ AR amp p = 0.037 
↑ GBA amp p = 0.001 
'Hypsarrhythmia' 
↓ GBA freq p < 0.001 
↓ AR amp p = 0.040 
↑ AR freq p = 0.042 'Ictal' 
↓ GBA freq p = 0.004 
'Post-ictal' ↓ GBA freq p = 0.004 
↑ AR amp p = 0.003 
↑ GEA amp 
↑ GBA amp p = 0.006 
Male gender ↓ GBA freq p = 0.009 
↑ GBA amp p = 0.018 
GEA patients (N = 325) 
CBRDEE 
↓ GBA freq p = 0.004 
↓ GEA freq ↓ GBA freq p = 0.005 
'Post-ictal' ↓ AR freq p = 0.004 Patients with RBS GEA (N = 57) 
Male gender ↓ AR freq p = 0.033 
↑ = higher. ↓ = lower. Amp = amplitude. Freq = frequency. CBRDEE = current brain related 
disease except epilepsy 
 
AR amplitude, AR frequency, GBA amplitude, and GBA frequency were all pairwise 
correlated (p < 0.001) (Fig. 17). Lower AR frequency correlated with higher AR amplitude, 
higher GBA amplitude, and lower GBA frequency.
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 Figure 17 Pairwise correlation (Spearman’s) between AR amplitude, AR frequency, GBA amplitude, and GBA frequency in 325 consecutive GEA patients (red) and 
3268 controls (green). Each background activity variable is plotted against the other ones. Histograms show the number of EEGs with identified AR/GBA 
amplitude/frequency in EEGs with GEA and in controls. The black lines in the histograms indicate the normal distribution. 
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8.4.2 GEA –and GEA-related features 
GEA amplitude and GEA frequency were not correlated (p = 0.35), nor was the probability 
of HVS and PPR (p = 0.54). 
GEA amplitude 
GEA amplitude changed with age in GEA patients (p<0.001) (Fig. 18a), also if adjusted for 
other significant covariates (p < 0.001). ‘Ictal’ EEG and EEG with RBS GEA correlated 
with higher GEA amplitude (p < 0.001). GEA amplitude changed with age also in the RBS 
GEA subgroup (p < 0.001). In this subgroup EEGs with ‘polyspike slow wave’ correlated 
with higher GEA amplitude (p = 0.029). 
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Figure 18 Fitted values for GEA amplitude (a) and GEA frequency (b) by age in 325 patients with GEA. 
Shaded areas are fitted values ± 1.96 SE. 
GEA frequency 
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GEA frequency did not change with age (Fig. 18 b). This was true also when adjusted for 
significant covariates, and also in the RBS GEA subgroup. ‘Polyspike’ correlated with 
higher GEA frequency (p < 0.001), while ‘ictal’ correlated with lower GEA frequency (p = 
0.002). In the RBS GEA subgroup no other GEA-features correlated with GEA frequency. 
Hyperventilation sensitivity (HVS) 
The probability for HVS did not change with age, even if adjusted for other GEA features. 
RBS GEA increased the probability for HVS (OR = 12.7, p < 0.001). 
In the RBS GEA subgroup the probability for HVS did not change with age, neither if 
adjusted for other significant GEA features. Higher probability for HVS correlated with the 
GEA-type ‘spike/sharp slow wave’ compared to ‘polyspike slow wave’ (OR = 9.0, p = 
0.005). 
Photoparoxysmal response (PPR) 
The probability for PPR changed with age with a maximum probability at 11 years, but only 
after adjustments for other significant GEA features (p = 0.011) (Fig. 19). Higher probability 
for PPR correlated with ‘polyspike slow wave’ (OR = 4.9, p = 0.002), ‘poly-spike’ (OR = 
32, p < 0.001), female gender (OR = 3.8, p = 0.001), and no medication (OR = 3.0, p = 
0.003). 
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 Figure 19 Age-related predicted probability for PPR in 259 GEA patients who had been provoked with flicker 
stimulation. The predicted probabilities are adjusted for significant predictors such as ‘polyspike slow wave’, 
‘poly-spikes’ ‘gender’, and ‘medicated’. Shaded areas are predicted values ± 1.96 SE. 
Regular bilateral synchronous (RBS) GEA 
The probability for RBS GEA changed with age (p = 0.021) with maximum probability at 11 
years (Fig. 20). This age-related probability was also present when adjusted for other 
significant covariates (p = 0.002). Higher probability for RBS GEA correlated with higher 
GEA amplitude (p < 0.001). 
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Figure 20 Predicted probability for RBS GEA by age in 325 GEA patients. Shaded areas are predicted values 
± 1.96 SE. 
Focal epileptiform activity (FEA) 
The probability for FEA did not change with age. Lower probability for FEA correlated with 
‘polyspike slow wave’ compared to ‘spike slow wave’ (OR = 0.43, p = 0.026). 
 
GEA-types 
The occurrence of ‘irregular spike/sharp slow wave’ pattern increased with age (p = 0.003) 
compared to the reference-group ‘spike/sharp slow wave’ (Fig 21). ‘Hypsarrhythmia’ 
decreased with age (p = 0.016) and was not seen after age 1 year. The other GEA-types were 
not age-related compared to the reference-group ‘spike/sharp slow wave’. 
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Figure 21 Age-related probability of different GEA types in 325 consecutive GEA patients. 
Current brain-related disease except epilepsy (CBRDEE) 
The probability of having CBRDEE increased by age (p = 0.013) (Fig. 22), also if adjusted 
for other significant covariates (p < 0.001). Patients with ‘polyspike slow wave’ had lower 
probability of having CBRDEE compared to ‘spike slow wave’ (OR = 0.18, p = 0.006). 
Lower GBA frequency correlated with higher probability of having CBRDEE (p < 0.001). 
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Figure 22. Age-related probability of current brain-related disease except epilepsy (CBRDEE) in 325 
consecutive GEA patients. 
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9. Discussion 
9.1 Methodological considerations 
9.1.1 Inter-system communication 
At the start of the project, there was no standard way of communicating with the actual EEG 
Editor. Windows API calls were therefore used to get information from the editor, whereas 
commands to the editor were accomplished by sending keystrokes. An automation interface 
provided by the EEG software vendor was later applied to meet these needs (Fig. 23). This 
made the EAS more robust. 
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Fig. 23. Overview of the EEG annotation system (EAS) (red) and its communication with the Nervus® EEG 
system (blue) including Nervus EEG editor, Nervus StudyRoom Database (a database connected to the Nervus 
EEG editor), and the hospital patient administrative system (green). ODBC: Open Database Connectivity, MS: 
Microsoft® 
9.1.2 Definitions 
Assessment of the EEG BA is essential in EEG evaluation as slowing is indicative for brain 
pathology (Dustman et al., 1993; Babiloni et al., 2006). The term “EEG background 
activity” is, however, not uniformly used in international EEG literature. “Background 
activity” or “background rhythm” is sometimes used synonymously with AR (Adamis et al., 
2005; Rodriguez et al., 2007). This is, according to authoritative standards, explicitly not an 
encouraged terminology (Chatrian et al., 1983). AR is a separate part of the EEG BA. We 
accordingly defined the GBA as the BA apart from the AR. The GBA activity is a more 
complex entity to describe compared to the AR. GBA is not a stable rhythm or frequency, 
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but rather a combination of several frequencies and amplitudes. The evaluation of the GBA 
in visually assessed EEGs is in previous EEG literature based upon categorisation into 
categorical groups (Ueberall et al., 1997; Londos et al., 2003). Such categorical variables are 
dependent on relating the BA to what is “appropriate for age”, which has previously never 
been established in objective terms. We therefore chose to measure the GBA directly 
according to frequencies and amplitudes. The GBA amplitude and frequency had previously 
not been described in a large EEG material, and therefore no established consensus on how 
to measure these parameters was available. GBA amplitude and frequency was measured as 
one or more amplitude and frequency ranges. However, for use in the present scientific 
studies, the lowest GBA frequency and the mean of the lowest and highest value for the 
GEA amplitude were chosen. The lowest GBA frequency was chosen because this was 
assumed to be most relevant for assessing EEG pathology (Gloor et al., 1977). This choice, 
however, implied that higher GBA frequencies were highly under-reported. 
9.1.3 Data collection 
The data collection was accomplished through routine assessment of EEGs in a busy clinical 
practice. This study-design provided a very large dataset, but could at the same time result in 
less accuracy compared to a focused assessment of a limited numbers of EEGs. As shown in 
paper II, there were some systematic differences between the different EEGers, but always 
with the same trends. We have therefore no reason to suspect that systematic assessment bias 
has affected the results. 
The BA often varies considerably through a routine EEG registration, with the degree of 
alertness as a main factor determining this variation. The AR was therefore measured in a 
segment where it was most distinctly appearing, and the GBA was measured during the most 
alert part of the registration. If drowsy, the patients were activated by activation procedures. 
9.1.4 Control group 
There are no established age-adjusted normal values established for the AR and GBA 
amplitudes and frequencies. In paper III and IV we therefore used a control group 
established from EEGs from not medicated outpatients without EEG pathology. This was 
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thus a sample of normal EEGs based on EEG findings, and not on clinical criteria. We 
excluded inpatients and medicated patients from the control sample to minimize 
confounding influence from medical effects and from complicating medical disorders. 
9.1.5 Statistics 
In paper II and paper III we used a multivariate polynomial model (MPM) to analyse age-
related amplitude and frequency variation. The MPM appeared unstable at high patient age 
due to few registrations. Individuals above the age of respectively 85 and 60 years in 
publication II and III were therefore excluded from these analyses. This was thus a problem 
in paper III, but not to the same degree in paper II. To avoid excluding the older part of the 
population we applied another and more recent statistical model in paper IV; the multivariate 
fractional polynomial model (MFPM) (Royston and Sauerbrei, 2005). 
(Royston and Sauerbrei, 2005) describe a dichotomy between nonparametric local-influence 
models and parametric global-influence models. The fit at a given point in the nonparametric 
local-influence model is strongly influenced by the neighbour points, but hardly affects the 
fit at remote points. Such models are highly flexible, but are also prone to artefactual 
behaviour with small neighbourhood sizes. These models are, however, constricted for 
“smoothing function” and cannot be used for comparing individual selections. By contrast, 
parametric global-influence models may be less responsive locally to true variations of the 
response as well as to perturbations, but the fit at distant points can be affected, in some 
cases considerably affected. High-order polynomials are especially prone to this affection of 
remote parts of the fits, and this explains our experience of instability of the model used in 
papers II and III. Both MPM and MFPM are examples of parametric global-influence 
models. The MFPM also exhibits global influence, but is more flexible than the MPM, and 
may provide satisfactory fits where high-order MPM may fail (Royston and Altman, 1994). 
By using MFPM in paper IV, we avoided excluding the oldest part of our population even 
though the number of observations were lower than in paper III. The MFPM is in this thesis 
also applied on the data from paper III (Fig. 24 and Fig. 25) (unpublished data). However, all 
the conclusions were the same using this new statistical method, irrespective of the patients 
above the age of 60 years being excluded or not. The fitted curves were comparable, but 
with less local variations using the MFPM compared to MPM. This shows the superiority of 
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MFPM to MPM in describing our datasets, but in our case without affecting the conclusions. 
The MPM model had, on the other hand, an advantage compared to the MFPM in the way 
we used it by including the possibility for interaction between variables. This possibility has 
recently been included also in the MFPM model, but too late to be included in paper IV 
(Sauerbrei et al., 2007). 
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Fig. 24 AR frequency (a) and AR amplitude (b) from all patients with FEA and from drug-free outpatient 
controls. AR frequency (c) and AR amplitude (d) from drug-free outpatients with FEA and from drug-free 
outpatient controls. (Unpublished data) 
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Figure 25. GBA frequency (a) and GBA amplitude (b) from all patients with FEA and from drug-free 
outpatient controls. GBA frequency (c) and GBA amplitude (d) from drug-free outpatients with FEA and from 
drug-free outpatient controls. (Unpublished data) 
 
9.2 General discussion 
9.2.1 The EEG annotation system (EAS) 
The described EAS provided storage of EEG-findings in a structured and standardized way 
without significant extra time consumption for the EEGers. Description databases of 
categorized EEG findings had previously been established  (Webber et al., 1989; Chung and 
Clancy, 1991; Lesser et al., 1993). Subsequent EEG databases have also been reported 
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(Finnerup et al., 1999; Hunter et al., 2005; Loddenkemper et al., 2007). However, none of 
them had direct communication to the EEG software and thereby direct linkage of database-
stored categorized EEG epochs to the raw data (Penzel et al., 2002). Another new quality of 
the EAS is the method for data input and for automatic data retrieval. The same database 
could have been obtained without the inter-system communication described, but this would 
demand far more parameters to be manually determined, and thereby much more time used. 
The explicit numerical representation of the BA described by the frequencies and amplitudes 
was instrumental for papers II-IV. The dichotomy of the BA divided into the AR and the 
GBA was furthermore crucial to be able to assess the BA in papers II-IV. 
Good access to appropriate information is essential for quality and effectiveness in daily 
routine work for the EEGer. In a later version of the EAS I have also implemented an 
overview tool providing a resume of previous EEG findings for the actual patient. The 
previous recordings are presented in a hierarchical view with the patient as the root, the 
individual recordings as branches, and the findings from each recording as sub-branches 
(Fig. 26). Marking the patient at the root will provide a graphical overview with all findings 
of the actual patient superimposed on a head model. The graphical overview will change 
according to the marked element; marking a recording will provide an overview of all 
findings of that recording, whereas marking of a finding will provide a graphical 
presentation of that single finding. Using this tool the EEGer can get a quick but still 
comprehensive overview of the patient’s EEG history, and also retrieve appropriate EEGs 
and EEG reports for comparison. 
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Fig. 26. Overview tool from the EEG annotation system (EAS) showing the graphical resume on a head model 
of all the patient’s EEG recordings, dynamically changing as the patient or individual EEG recordings are 
selected (marked with a blue horizontal bar). Vertical lines indicate epileptiform pathology. Horizontal lines 
indicate non-epileptiform pathology. Yellow colour indicates normal findings and variants. Black circles 
indicate maximum electrodes. 
9.2.2 EEG background activity (BA) 
Evaluation of the BA, represented by AR and GBA, is an important part of visual EEG 
evaluation as BA slowing indicates CNS pathology (Guerrini, 2006; Pillai and Sperling, 
2006; Smit et al., 2006; Tedrus et al., 2006a). GBA, assessed as frequencies and amplitudes, 
was for the first time collected and analyzed from a large number of EEGs from infancy to 
old age in paper II. These variables proved to be different in drug-exposed and drug-free 
patients, and in patients with and without non-GBA pathology in their EEGs. 
EEG BA is often described as “appropriate for age” or not. Background slowing is often 
mentioned without any defined amplitude limits (Hughes and Cayaffa, 1977; Raymond et 
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al., 1995; Loddenkemper et al., 2007). No standards exist for appropriate GBA frequencies 
and amplitudes in visually assessed EEGs. As there was no available control group of 
documented healthy volunteers, no normal values in the strict sense could be established 
from our database. The age-related values from our not medicated patients without AR and 
GBA pathology, did, however, describe typical values at different ages. Furthermore, 
analysing the EEGs described as normal, maximal amplitudes at different ages could be 
suggested as the 95 percentile for each frequency band. According to these findings, the 
mean GBA amplitude in the theta frequency range should for example not exceed 30 µV in a 
normal EEG in subjects above the age of 20 years, and mean delta GBA amplitude should 
not exceed 60 µV in children aged 0-4 years (Fig. 8). The lowest GBA frequency was 
always chosen for this analysis, so higher GBA frequencies were grossly under-reported. 
The selection of the lowest frequency was, however, not necessary in this setting as the 
different frequency bands were described separately. In this thesis, I have therefore 
reanalysed the mean GBA amplitudes of all the frequency ranges from the control group 
from paper III and paper IV (N=2368) (Fig. 27) (unpublished data). These reanalyzed data 
gave a better representation of higher GBA frequencies. 
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Fig. 27. Relationship between GBA frequency bands (delta, theta, alpha, and beta), amplitude, and patient age 
in 3268 not medicated outpatients without EEG pathology. The boxes indicate the 25th and 75th percentiles, 
blue lines within the boxes mark the median. Whiskers indicate the 10th and 90th percentiles, and red dots 
indicate the 5th and 95th percentiles. 
Life span age-specific GBA frequency and amplitude have previously not been published. 
There has therefore until now not been any scientific basis for ‘GBA appropriate for age.’ 
Paper II and the modification in Fig. 27 indicate such values, and should be useful in the 
education of EEG interpreters. 
The physiological background for the life-span changes of the frequencies and amplitudes of 
the BA is not evident. Mechanisms such as changes in bone density and corresponding 
increase in electrical impedance of the intervening tissue have been proposed (Dustman et 
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al., 1999). A recent study demonstrated gray matter volume decrease in the frontal and 
parietal cortex, with the greatest change occurring in adolescence, and suggested that the 
corresponding elimination of active synapses was responsible for the observed reduction in 
EEG power (Whitford et al., 2007). (Boord et al., 2007) found in a lifespan study a 
correlation between decreased EEG power and decreased cerebral metabolic rate. This 
supports the view that the reduced EEG power by age is due to reduced synaptic activity. 
Paper III and IV showed BA slowing in patients with epileptiform activity compared to the 
control group. As a general principle, we first compared the total study group with the 
controls adjusted for age and gender only. Subsequently subgroups were compared to the 
same controls trying to identify confounding factors. Such confounding factors could be 
medication and complicating medical disorders. In paper III the subgroup of drug-free 
outpatients with FEA was therefore compared with the control group. This comparison still 
revealed BA slowing in the FEA group. The drug-free outpatients with FEA could, however, 
still have complicating medical disorders, and more or less so than the controls. To further 
investigate this possibility I have now also analysed the subset of drug-free outpatients and 
controls from the paper III study after all the individuals with brain-related ICD10-diagnoses 
other than epilepsy were excluded, retaining 146 drug-free outpatients with FEA and 1559 
controls (unpublished data). The patients with FEA still had higher GBA amplitude 
compared to controls (p < 0.001), while there was no difference in GBA frequency, AR 
frequency, and AR amplitude. Another weakness regarding the comparison between the 
FEA group and the control group was that presence of non-epileptiform pathology by 
definition lead to exclusion in the control group, but not in the FEA group. I have therefore 
now analysed the subset of drug-free outpatients and controls from the paper III study where 
all individuals with brain-related ICD10-diagnoses other than epilepsy were excluded, and 
also excluded all EEGs with non-epileptiform pathology, retaining 106 drug-free outpatients 
with FEA and 1559 controls (unpublished data). The patients with FEA still had higher GBA 
amplitude compared to controls (p < 0.014), while there was no difference in GBA 
frequency, AR frequency, and AR amplitude. This finding supports the association between 
FEA per se and EEG BA slowing and is consistent with quantitative EEG studies (Diaz et 
al., 1998; Tedrus et al., 2006b). It should, however, be emphasised that our study is EEG 
centred, and not a clinical study directly applicable to specific epilepsy types. 
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High GEA amplitude was found to correlate with GBA slowing. The amplitude of the GEA 
spikes has to the best of my knowledge not previously been studied. The amplitude of scalp 
recorded epileptiform spikes and ictal rhythms depends on multiple factors such as the size 
of the cortical area involved, localisation of this area, orientation of the electrical field, 
degree of synchrony, and the amplitude of the original cortical signals (Ebersole and Hawes-
Ebersole, 2007). The correlation between high GEA amplitude and GBA slowing could 
indicate larger cortical areas involved with high GEA amplitudes. 
Even though the group with GEA showed more EEG BA slowing compared to the control 
group, this could be due to confounding factors as mentioned above. Because of the limited 
number of EEGs with GEA compared to FEA, and limited statistical power, a similar 
subgroup of not medicated outpatients was not applied for the GEA EEGs. We are therefore 
not able to correlate GEA and EEG BA slowing as specifically as for FEA. The distinct 
GEA characteristics could, however, be studied within the whole group of patients with 
GEA to weight the individual components’ influence on the EEG BA. 
Even though quantitative EEG (qEEG) measures are used in most EEG studies, the visually 
assessed EEG is still most used in daily clinical practice. The next step for the functionality 
of the EAS should be to incorporate the use of qEEG in the same system, and thereby 
combine the use of visually assessed EEG with qEEG. The different methods could then be 
compared, and the gain of each modality could be evaluated. 
There is also a need for more accurate clinical information in the database. The referral 
diagnoses and the clinical ICD10 diagnoses set by the doctors treating the patients in the 
hospital are not always sufficiently sensitive and specific for exact disorders. Good clinical 
endpoints are necessary to correlate EEG findings to clinical settings. Standardised 
comprehensive and accurate clinical descriptions of normal individuals as well as of selected 
patient groups at different ages should therefore be included. 
9.2.3 Characteristics of epileptiform activity 
The age-related topographical distribution of FEA was described in paper III. Age-related 
epilepsies, such as occipital epilepsies and benign partial epilepsy in childhood explain some 
of the observed variation. Migration of epileptic foci could also contribute to such age-
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related change of distribution, although this phenomenon has been debated (Blume, 1990; 
Andermann and Oguni, 1990). The amplitude maximum of spikes recorded from scalp EEG 
does not necessarily correspond directly to the underlying focus in the cerebral cortex due to 
neuronal propagation from distant areas as well as to peculiarities in the brain coverings 
such as skull holes (Torre et al., 1999). This has to be taken into consideration when 
applying the topographical distribution of FEA in clinical practice. 
Paper IV demonstrated accurately the age-related occurrence of individual GEA-types.  
Higher GEA amplitude and lower GEA frequency correlated with slowing of the EEG BA, 
and slowing of the EEG BA correlated with CBRDEE. This was in accordance with the 
generally accepted theorem that low-frequency GEA indicates symptomatic epilepsy 
(Markand, 2003; Smith, 2005; Pillai and Sperling, 2006). The amplitude of scalp recorded 
epileptiform spikes and ictal rhythms depends on multiple factors such as the size of the 
cortical area involved, localisation of this area, orientation of the electrical field, degree of 
synchrony, and the amplitude of the original cortical signals (Ebersole and Hawes-Ebersole, 
2007). The electrical potentials decrease in inverse proportion to the square of the distance 
from the origin, and conduction through various tissues with different conduction rates 
attenuate the amplitudes (Hashiguchi et al., 2007). Our study showed that EEGs with RBS 
GEA and with ictal manifestations had higher GEA amplitudes. This could be a direct effect 
of a higher degree of synchrony or of a larger cortical area involved (Tao et al., 2007; 
Ebersole and Hawes-Ebersole, 2007). The decrease of GEA amplitude with age could in part 
be due to less synchrony related to a higher proportion of ‘irregular spike/sharp wave’. 
However, higher GEA amplitudes remained correlated with GBA slowing also after 
adjusting for these factors. This shows that high GEA amplitude is correlated to a general 
affection of cortical activity independent of age and other GEA-related features. This 
knowledge extends our understanding of GEA and helps the EEGer in weighing the various 
GEA components. 
The probability for PPR changed with age, while the probability of HVS did not. The 
probabilities for PPR and HVS were not correlated. This indicated that HVS and PPR were 
complimentary in increasing the yield of the EEG registration. A consequence of these 
findings is that there should be no upper age-limit for HVS. 
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10. Conclusions 
We have developed a comprehensive EAS providing storage of EEG-findings in a structured 
and standardized way. This system provided improved accessibility of EEG data for clinical, 
educational, and scientific use. 
The age-related development of the AR and GBA was described, and also the association 
with gender, medication, non-AR pathology, and non-GBA pathology. 
Topographical distribution of FEA was age-dependent for all brain regions except for the 
temporal region. Frontal FEA was more frequent in adults, whereas central, parietal, and 
occipital FEA were more frequent in children. 
GEA amplitude changed by age, whereas GEA frequency did not. Higher GEA amplitudes 
and lower GEA frequencies correlated with GBA slowing. GEA amplitudes and GEA 
frequencies did not correlate. 
The probability for PPR and for RBS GEA changed with age with a maximum at 11 years. 
The probability for HVS did not change with age, nor did the probability for FEA combined 
with GEA. The probability for HVS and PPR did not correlate. HVS and PPR are thus 
complimentary in increasing the yield of the EEG registration. There should be no upper 
age-limit for HVS. 
FEA was associated with slowing of the EEG BA. Slowing remained significant in the 
subgroup of not medicated outpatients, suggesting that the association was due to the FEA 
per se. Also GEA was associated with slowing of the EEG BA. Due to confounding factors 
such as medication and complicating medical disorders, the exact association between GEA 
per se and this slowing of the EEG BA could not be established. 
The age-related probability for specific GEA-types was established. 
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12. Errata 
1. Paper I, page 988: Code 3.A.95 should be corrected to 3.A.05 
2. Paper I, page 992: Age should be 46 (not 66) 
3. Paper II, page 666: The study period should be March 1, 2000 to March 1 2002 (not 
January 1, 2000 to March3, 2002) 
